Mar 02, 2016 13:00 pm UTC| Business
Total Company Q4 Revenue of$77.9million; Total Company Full Year Revenue of $306.1 MillionQ4 Revenue from Continuing Operations of $48.9 Million; $193.2 Million for Full YearTotal Company Q4 EPS of$0.37; Full Year Net Loss...
Xcel Brands Announces New Credit Facility With Bank Hapoalim
Mar 02, 2016 13:00 pm UTC| Business
NEW YORK, March 02, 2016 -- Xcel Brands, Inc. (NASDAQ:XELB) (“Xcel” or the “Company”), a brand development and media company, today announced that it has completed a refinancing of its senior debt with Bank Hapoalim...
Qorvo® to Present at Raymond James 37th Annual Institutional Investors Conference
Mar 02, 2016 13:00 pm UTC| Business
GREENSBORO, N.C. and HILLSBORO, Ore., March 02, 2016 -- Qorvo® (Nasdaq:QRVO), a leading provider of core technologies and RF solutions for mobile, infrastructure and defense applications, today announced that Company...
ScottsMiracle-Gro Completes Minority Investment in Bonnie Plants
Mar 02, 2016 13:00 pm UTC| Business
MARYSVILLE, Ohio, March 02, 2016 -- The Scotts Miracle-Gro Company (NYSE:SMG), the world’s leading marketer of branded consumer lawn and garden products, today announced it has completed a minority economic investment...
Edge Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference
Mar 02, 2016 13:00 pm UTC| Business
BERKELEY HEIGHTS, N.J., March 02, 2016 -- Edge Therapeutics, Inc. (Nasdaq:EDGE), a clinical stage biotechnology company developing novel hospital-based therapies in the management of acute, life-threatening conditions,...
EyeGate Receives Additional Milestone Payment From Valeant Pharmaceuticals for EGP-437
Mar 02, 2016 13:00 pm UTC| Business
WALTHAM, Mass., March 02, 2016 -- Eyegate Pharmaceuticals, Inc. (NASDAQ:EYEG) (“EyeGate” or the “Company”), a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug...
Insmed to Present at the 36th Annual Cowen & Company Healthcare Conference
Mar 02, 2016 13:00 pm UTC| Business
BRIDGEWATER, N.J., March 02, 2016 -- Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today reported that company management will...